Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Workspace lets out HQ office to Wild Cosmetics

(Sharecast News) - Workspace Group has announced a new five-year lease at its Kennington Park site in London, giving up its own headquarters to Wild Cosmetics as the office management company relocates to Camden. Following its acquisition by Unilever, Wild Cosmetics is nearly doubling its space in Kennington Park from 7,500 square foot to 14,000 square feet, while Workspace will move its base operations to The Centro Buildings.

The deal was agreed at a net rent of £42 per square foot amid "positive momentum with other large space lettings", Workspace said.

The company, which recently announced two lettings at Kennington Park for a total of nearly 16 square foot, said it expects the new HQ move to happen in October.

"Wild has been a major disruptor within the cosmetics sector in recent years and has seen phenomenal growth since taking their first space with us six years ago. We're proud to have played a part in Wild's journey - so much so that we're moving out of our head office at Kennington Park to make way for their expansion," said Workspace's chief executive Lawrence Hutchings.

"This enables us to relocate our HQ to the Centro Buildings in Camden where our presence will have both a positive impact on occupancy and support the leasing of Atelier House, part of the Centro Building site. Atelier House is being refurbished into our small studio format opening early next year to serve the creators, innovators, disruptors and creators in this vibrant SME market."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.